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ABSTRACT 
Stromal cells derived from the adipose tissue (ADSCs) have self-renewal capabilities 
and the capacity to differentiate along different mesenchymal and epithelial lineages, 
including the osteoblast phenotype. Additionally, these cells can be easily harvested 
trough a minimal invasive surgical procedure, as comparing to the harvest of stromal 
cells from other sources, such as the bone marrow. This characteristic has made their 
application potentially useful in regenerative medicine approaches, particularly within 
the bone regenerative process. While widespread data is available on the impact of fat 
tissue harvest and cell isolation procedures for adequate ADSCs functionality, little 
attention has been given to the anatomical differences verified within the fat tissue, as 
well as the impact of these differences on the functional activity of ADSCs. 
Accordingly, this experimental work aimed the isolation and characterization of ADSCs 
fƌoŵ ƌat͛s adipose tissue, harvested from different anatomical locations, i.e., 
subcutaneous inguinal, abdominal inguinal, flank, neck and omentum. Following, 
grown cells were characterized, following specific induction, regarding osteogenic 
differentiation capability through biochemical, histochemical, gene expression and 
microscopical techniques, in two-dimensional (monolayer) and three-dimensional 
(spheroids) culture systems.   
Established ADSC cultures from distinct anatomical locations revealed a distinct 
biological behavior. In regards to the proliferative capacity, abdominal inguinal 
revealed the highest potential, while the osteogenic capability was highest in cultures 
established from flank. ADSCs derived from all anatomical locations formed efficiently 
three-dimensional aggregates that maintained their viability during the culture period. 
Broadly, and given the verified functional differences of ADSCs grown from distinct 
anatomical locations, it might be adequately to address the fat tissue anatomical 
location in order to adequately select the populations most relevant for the specific 
targeted regenerative application.   
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RESUMO 
As células estromais derivadas do tecido adiposo (ADSCs) têm a capacidade de se auto-
renovarem e de se diferenciarem em linhagens mesenquimais, incluindo a linhagem 
osteoblástica. Além disso, estas células podem ser facilmente obtidas a partir de um 
procedimento cirúrgico minimamente invasivo, quando comparado com a recolha das 
células estromais de outros locais, nomeadamente da medula óssea. Todas estas 
características, fazem destas células estromais potencialmente úteis quando aplicadas 
num contexto de medicina regenerativa. Embora existem estudos acerca do impacto 
dos procedimentos da recolha do tecido adiposo e do isolamento das células estromais 
na funcionalidade das ADSCs, pouca atenção tem sido dada às diferenças anatómicas 
verificadas dentro do tecido adiposo, bem como o impacto dessas diferenças na 
atividade funcional das ADSCs.  
Deste modo, o trabalho experimental aqui presente tem como objetivo o isolamento e 
a caracterização das ADSCs derivadas de tecido adiposo de rato recolhido de 
diferentes localizações anatómicas, nomeadamente, inguinal subcutânea, abdominal 
inguinal, flanco, pescoço e omento. De seguida, as células cultivadas e submetidas a 
indução apropriada, foram caracterizadas tendo em conta a capacidade de 
diferenciação osteogénica, através de técnicas bioquímicas, histoquímicas, 
microscópicas e expressão génica em culturas a bidimensionais (monocamada) e a 
tridimensionais (esferóides). 
As culturas estabelecidas a partir das diferentes localizações anatómicas, revelaram 
um comportamento biológico distinto. Em relação à capacidade proliferativa, a zona 
abdominal inguinal revelou maior potencial, enquanto a capacidade osteogénica foi 
maior nas culturas estabelecidas do flanco. ADSCs derivadas de todas as localizações 
anatómicas formaram eficientemente agregados tridimensionais que mantiveram a 
sua viabilidade durante o período de cultura.  
Em termos gerais, e dadas as diferenças funcionais verificadas nas ADSCs cultivadas a 
partir das diferentes localizações anatómicas, poderá ser adequado ter em 
consideração o local anatómico de recolha do tecido adiposo a fim de selecionar as 
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populações celulares mais relevantes para uma aplicação direcionada em medicina 
regenerativa. 
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MESENCHYMAL STROMAL CELLS (MSCS) 
Mesenchymal stromal cells (MSCs) are adult stromal cells traditionally found in the 
bone marrow and originating from the mesenchyma, which is an embryonic tissue 
derived from the mesoderm [1]. But, MSCs can be found in other tissues, including 
adipose tissue, umbilical cord, muscle, periosteum, synovial membranes, trabecular 
bone, skin, tendons, dental pulp of deciduous teeth [1]–[4], and also, in organs such as 
the liver, spleen and lung [3]. 
These cells have the ability to differentiate into multiple lineages including adypocites, 
chondrocytes and  osteocytes [2] (see Figure 1). Moreover, MSCs play an important 
role as a support system for hematopoietic stem cells maturation and development, 
within the marrow  [2], [5]. 
 
 
Figure 1 Histological images from MSCs in monolayer culture (A) and following differentiation into 
three lineages: osteogenic (B) staining with von Kossa, adipogenic (C) staining with Nile Red O and 
chondrogenic (D), immunostaining with an antibody specific for type II collagen (adapted from (2)). 
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CHARACTERIZATION OF MESENCHYMAL STROMAL CELLS 
Over the time, there has been a controversy regarding the nomenclature used to 
described plastic-adherent cells isolated from bone marrow and other sources [4], [5]. 
“oŵe authoƌs used the teƌŵ ͞ŵeseŶĐhǇŵal steŵ Đells͟ aŶd otheƌs sustaiŶ the teƌŵ 
͞ŵeseŶĐhǇŵal stƌoŵal Đells͟. The IŶteƌŶatioŶal “oĐietǇ foƌ Cellulaƌ TheƌapǇ pƌopose 
that plastic-adherent cells, regardless of the tissue from which they are isolated, 
normally designated as mesenchymal stem cells can be, more adequately regarded as 
͞ŵultipoteŶt stƌoŵal Đells͟, ǁhile the teƌŵ ͞ŵeseŶĐhǇŵal steŵ Đells͟ is used foƌ the 
Đells that ŵeet speĐified steŵ Đell Đƌiteƌia. The aĐƌoŶǇŵ ͞M“C͟ ĐaŶ ďe used iŶ ďoth 
situations [4].  
The disĐussioŶ aďout the ŶoŵeŶĐlatuƌe to ďe adopted ƌelates to the teƌŵ ͞steŵ͟, 
siŶĐe it pƌesupposes ͞the loŶg-term self renewing cell that is capable of differentiation 
into specific multiple cell types in vivo” [4]. Nevertheless, this criterion is not always 
analyzed or observed in isolated cell populations and, moreover, the plastic-adherent 
cells isolated are quite heterogeneous, so, in these situations, it is better to use the 
term multipotent or mesenchymal stromal cells without ascribing homogeneity or 
stem cell activity [4]. 
Throughout this work, the term mesenchymal stromal cells, as well as the acronym 
MSCs, to define this cell population, will be used. 
Immunologically, mesenchymal stromal cells (MSCs) are characterized by using specific 
markers, however that characterization is hampered by a lack of a determining and 
specific single cell marker for MSCs populations [6]. The International Society for 
Cellular Therapy proposed three minimal criteria for the identification and 
characterization of cultured human MSCs: (i) plastic adherence when maintained in 
standard culture conditions, (ii) expression of CD73, CD90 e CD105 and lack of CD11b 
oƌ CDϭϰ, CDϭ9 oƌ CDϳ9α, CDϰϱ aŶd HLA-DR expression, and (iii) their trilineage 
differentiation potential into adipocytes, chondrocytes and osteoblasts under standard 
in vitro differentiating conditions [4], [6]. 
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Phenotypically these cells express a number of surface markers that are not phenotype 
specific. However, it is known that adult human MSCs do not express the 
hematopoietic markers CD45, CD34, CD14 or CD11a [7], [8]. These cells also do not 
express the costimulatory molecules CD80, CD86 and CD40, or the adhesion molecules 
CD31, CD33 and CD56, but they can express CD105, CD73, CD44, CD90 and Stro-1  [9]  
aŶd eǆhiďit high eǆpƌessioŶ of iŶtegƌiŶ αϭ, αϱ aŶd βϭ, loǁ eǆpƌessioŶ of αϭ, αϯ, αϲ,αV, 
βϮ aŶd βϰ, aŶd Ŷo eǆpƌessioŶ of αϰ, αL aŶd βϮ [2], [8]. The adhesion molecules CD106 
(vascular cell adhesion molecule), CD166 (activated leukocyte cell adhesion molecule), 
intercellular adhesion molecule (ICAM)-1 and CD29 are also broadly expressed [2], [8], 
[9]. In other species, the molecules expressed by MSCs may not be particularly the 
same and even within the same species, a variable expression pattern, due to 
variations in tissue source, the method of isolation and culture, may be verified [9]. 
The gold standard assay used to identify MSCs is the colony forming unit-fibroblast 
(CFU-F) assay, which can be used to identify the adherence and the morphology 
(characteristic spindle-shaped) that form colonies [10]. 
In a general way, MSCs isolation is based on their ability to adhere to the tissue culture 
plate and they are expanded by keeping their multipotency during the culture [3]. 
The MSCs isolated from fetal blood, liver, spleen and bone marrow, although 
phenotypically similar, showed heterogeneity in differentiation potential, which is 
directly related to the tissue source [9]. These examples illustrated that mesenchymal 
cells are phenotypically heterogeneous, and the relationship between traditional 
bone-marrow-derived MSCs and these other MSC-like populations remains to be fully 
clarified [9]. 
In vitro, M“Cs͛ haǀe the ĐapaďilitǇ to diffeƌeŶtiate iŶto distiŶĐt liŶeages, giǀiŶg ƌise to 
cell populations generally found in bone, fat and cartilage. To achieve this, it is 
necessary to supplement the culture medium with specific molecules and growth 
factors that modulate genetic events, thus involving transcription factors [11]. The 
differentiation to a particular phenotype pathway can be controlled by some 
regulatory genes that can induce progenitor cell differentiation to a specific lineage 
[11]. Moreover, basal nutrients, cell density, spatial organization, mechanical forces, 
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growth factors and cytokines, influence, in a large part, the MSCs differentiation 
process [10]. Other factors, broadly related to the donor characteristics (like age, 
gender, presence of trauma or systemic disease), may also influence the yield and 
expansion of MSCs [8]. 
SOURCES OF MESENCHYMAL STROMAL CELLS 
As already mentioned, the MSCs can be found in several tissues. In the literature, the 
tissues most studied are bone marrow, adipose tissue, umbilical cord blood, synovium 
membrane, muscle and teeth. 
Bone marrow derived mesenchymal stromal cells (BMSC) 
Alexander Friedenstein and their co-workers were the first to isolate bone marrow 
stem cells [12]. They placed bone marrow in plastic culture dishes and removed the 
non-adherent cells after 4 hours, thus discarding most of the heterogeneous cells. 
They concluded that the adherent cells were heterogeneous in appearance, but the 
most adherent cells were spindle-shaped and formed foci of two to four cells, which 
remained inactive for 2-4 days and then began to proliferate rapidly [9]. After some 
time in culture, the adherent cells became more homogeneously fibroblastic in 
appearance [9]. 
The main characteristics of BMSCs are the ability to form fibroblastic-like colonies, 
extensive proliferative capacity, the ability to express several common cell surface 
antigens and, also, the ability to differentiate into several mesodermal lineages [13]. 
Because of these characteristics, bone marrow stem cells may potentially be useful in 
the field of regenerative medicine. However, they show some disadvantages compared 
to other sources. The percentage of MSCs in bone marrow was found to be very low, 
about 0.001% to 0.01% [14]. Further, it has been demonstrated that the potential of 
differentiation and the yeld of cells decreases with age [15]. Further, the harvest 
procedure is invasive and can cause pain and morbidity to the donor site [16], [17]. 
Thus, alternative sources of mesenchymal stem cells have been investigated. 
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In humans, the MSCs are generally isolated from an aspiration of bone marrow, 
harvested from the superior iliac crest of the pelvis, from the tibial and femoral 
marrow compartments and thoracic and lumbar spine. In rodents it is harvested from 
the mid-diaphysis of the tibia or femur [18]. 
Numerous studies show that adult bone-marrow stem cells can regenerate non-
hematopoietic tissues, like brain, skeletal muscle, liver and epithelium, endothelium 
and heart [18], but the clinical validity of these approaches originated a lot of 
controversy and discussion within the scientific community. 
The selective differentiation of precursor cell populations, in vitro, depends on the 
specific environmental cues combined with growth factors and cytokines supplied into 
the culture medium [19]. Many studies have evaluated the expansion and the 
diffeƌeŶtiatioŶ of BM“Cs usiŶg a ǀaƌietǇ of ďasal ŵedia, iŶĐludiŶg α-Modified Eagle 
Media ;α-MEMͿ, DulďeĐĐo͛s Modified Eagle Mediuŵ-High Glucose (DMEM-HG) and 
DulďeĐĐo͛s Modified Eagle Media-Low Glucose (DMEM-LG) [20], but have broadly 
demonstrated that media ďased oŶ α-MEM were more suitable for the expansion of 
human BMSCs [20]. 
Adipose-derived mesenchymal stromal cells (ADSCs) 
Adipose tissue has gained a lot of interest in the last years since the validation of the 
possible to isolated mesenchymal stromal cells from this tissue. Isolated cells reported 
to ability to self-renew and differentiated into the classical lineages: adipogenic, 
osteogenic and chondrogenic [21]–[23].  
Due to the importance of the adipose tissue as a source of stromal cells to the present 
work, this issue will be further developed in detail. 
Umbilical cord blood derived mesenchymal stromal cells (UCB-MSCs) 
The umbilical cord blood (UCB) can be a source for MSCs. However, the studies are 
controversy regarding the ability of UCB-derived cells to be capable to differentiate 
into cells of different lineages like bone, cartilage and adipose tissues [15], [16], [24]. 
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For instance, in a study from Wexler et al. [25] it was found  that UCB does not yield 
MSCs, in the culture systems that are usually performed, despite that authors could 
not exclude the possibility that MSCs could be present in UBC. Another study showed 
the failure to obtain MSCs from UCB, concluding that in comparison to BMSCs, the 
stem cells from UCB do not express the general characteristics of MSCs [26]. 
On the other hand, Erices et al. [27] demonstrated that cells from UCB are able to 
generate adherent cells in culture and they express the phenotype similar to the one 
attained by a mesenchymal-like populations. 
Goodwin et al. [28] were able to isolated mesenchymal stem cells from UCB and 
differentiated them in multiples lineages, like osteogenic, adipogenic, neurogenic and 
chondrogenic, and they concluded that UCB-MSCs can differentiate into osteoblasts 
and adypocites, but not into chondrocytes, still remaining the ability to express 
neuronal markers.  
In a study that compared MSC from bone marrow, umbilical cord blood and adipose 
tissue [16] in terms of success rate of isolation, expansion potential, multiple 
differentiation and immune phenotype, the conclusion for UBC-MSCs was that they 
didŶ͛t shoǁ aďilitǇ to diffeƌeŶtiate iŶto adipogeŶiĐ liŶeage ďut theǇ shoǁed 
chondrogenic and osteogenic differentiation capabilities. 
In general, there are some described advantages to the usage of cells from UCB, since 
the UCB can be easily obtained by a non-invasive method, given that after the delivery 
the umbilical cord and placenta are discarded [15].  
Synovium membrane-derived stromal cells (SM-MSCs) 
There are studies that report the ability to isolate MSCs from the synovium membrane 
[29], [30], and they show a capacity to proliferate in culture, maintaining multilienage 
differentiation potential in vitro. These cells may play an important role in regenerative 
applications for joint problems  [29]. 
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The SM-MSCs show a phenotype similar to that of MSCs form other tissues, since they 
express the typical markers such as CD44, CD73,CD90 e CD105, and do not express 
CD34, CD45, CD31 and CD14 [1]. 
Bari et al [29] isolated the synovium membrane-derived cells from the knee joint and 
differentiated them into multiples lineages (chondrocytes, osteocytes and adipocytes) 
and concluded that cells have the potential to properly differentiate in these lineages. 
In a study from Sakaguchi et al. [30] synovium cells demonstrated good ability for 
chondrogenesis, adipogenesis (the red O oil staining was highest in comparison to 
other analyzed sources) and osteogenesis (the rate of positive alizarin red staining was 
the highest too). Yoshimura et al. [31] even claimed that SM-MSCs are superior to 
bone marrow, adipose tissue, muscle derived cells in terms of colony number per 
nucleated cell and colony number per adherent cells; and comparing the different 
tissues, synoviuem-derived cells have the highest chondrogenic potential which can be 
used in cartilage-related tissue engineering approaches. 
Muscle-derived stromal cells (MDSC) 
Skeletal muscle tissue contains two different types of stem cells: satellite cells and a 
population of multipotent stem cells [1], [32]. Satellite cells are unipotent cells that are 
originated from a population of muscle progenitors during embryogenesis [1]. The 
population of multipotent stem cells, so called muscle derived stem cells (MDSC), seem 
to form a stable, self-renewing pool of stem cells in adult muscle exhibiting the ability 
to differentiate into a variety of cell types [32]. 
MDSC have high proliferation and self-renewable capacity, express markers CD34, Sca1 
aŶd doŶ͛t eǆpƌess Đ-Kit [1]. 
Teeth-derived stromal cells (T-MSCs) 
Stem cells can be found in either the dental pulp of deciduous teeth [33], [34], as 
within the periodontal ligament [1], [34]. Stem cells derived from human deciduous 
teeth are a readily accessible tissue source since they are routinely exfoliated in 
childhood, with little or no morbidity to the patient [34], [35]. 
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According to Miura et al. [33] and Seo et al. [35] stem cells from pulp of human 
deciduous teeth and periodontal ligament seems be a ideal source for repair bone 
defects in pediatric patients.  
Periodontal ligament-derived stem cells express the common markers from MSCs, like 
CD13, CD29, CD44, CD59, DC105 e STRO-1 [1]. Stem cells isolated from deciduous 
teeth also express MSC markers like CC9, MUUC18 and CD146. 
T-MSCs show osteogenic, adipogenic and chondrogenic differentiation. The induction 
into these lineages is similar the other MSCs [1], [34], [35]. 
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ADIPOSE-DERIVED STROMAL CELLS (ADSCS) 
The adipose tissue, like bone marrow, is derived from the embryonic mesoderm and 
contains a heterogeneous stromal cell population [22]. This stromal cell population is 
called stromal vascular fraction (SVF)  and include adipose stromal cells, hematopoietic 
stem cells, progenitor cells, circulating blood cells, fibroblasts, pericytes, endothelial 
cells, lymphocites, monocyt and macrophages [36], [37]. 
These cells, in vitro, were found to differentiate towards the osteogenic, adipogenic, 
myogenic, and chondrogenic lineages [37]. A lot of researchers claim the ADSCs 
differentiation into non-mesenchymal lineages [3], [17], [38], [39], however this 
plasticity is not accepted by the entire research community [6], [40]. 
The SVF cells in adipose tissue usually sum up to 3% of the total cell count, and this is 
2,500-fold more than the frequency of stromal cells in bone marrow [41]; in other 
words, adipose tissue provides larger numbers of stromal cells compared to bone 
marrow. A bone marrow transplant contains about 6x10
6 
nucleated cells per mL, of 
which only 0.001-0.01% are stromal cells  [14], [42], whereas the number of SFV cells 
that can be isolated from subcutaneous liposuction aspiration is approximately 0.5-
2.0x10
6 
cells per gram of adipose tissue [22], [42]–[44]. Other features distinguish 
ADSCs and BMSc: ADSCs seems to have an increased tendency for muscular 
differentiation than BMSc, but less robust un chondrogenic and osteogenic 
differentiation [37]. Further, and the adipose tissue is more easy of harvest than bone 
marrow. 
The Internation Federation for Adipose Therapeutics and Science (IFATS) and the 
Internation Society for Cellular Therapy (ISCT) proposed a combination of negative and 
positive markers to identify the SVF and the adherent stromal cells population  [37]. 
The markers CD13, CD29, CD44, CD73, CD105, CD90 (>40%) and CD34 (>20%) must be 
positive on SFV and the markers CD31 (<20%) and CD45 (<50%) must be negative on 
SFV [37]. 
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ADSCs should be further be negative for hematopoietic markers, including CD11b, 
CD45, CD34, CD19 and positive for CD13, CD73 and CD90 [6], [37]. CD36 and CD 106 
can be used to distinguish ASCs from MSCs from bone marrow [37]. 
The localization of stromal cell population within adipose tissue is complicated because 
there is not a single and specific marker that clearly identifies undifferentiated ADSCs. 
Recent studies suggest that a stem cell population resides in a perivascular location [3], 
[45], [46] and MSCs in general are a subset of pericytes or vascular stem/stromal 
precursor cells located near the vasculature  [3], [47].  
The pericytes are perivascular cells which appear in all tissues in contact with the 
intimal surface of small vessels [40]. Some studies show that cultured pericytes have 
the ability to differentiate, in vitro, into osteoblasts, adipocytes, chondrocytes and 
myocites, supporting the idea of a perivascular niche for MSCs  [48]. The cell 
population from this niche seems to express the markers CD34, CD90 and the absence 
of CD31, CD45 and CD146 expression [3]. 
Despite all of  these studies, the definite identification of the ASDC population in situ 
has not been found yet [3]. The niche (physiologically microenvironment that supports 
stem cells) is very important to control de self-renewal and differentiation, as well as 
function and phenotype of the ADSCs [49], [50]. 
ISOLATION OF ADIPOSE-DERIVED STROMAL CELLS 
There is no consensus in isolation protocol of ADSCs leading to distinct results and 
conclusion. The protocols used by different laboratories and work groups around the 
world differing in the type of tissue digestion (enzymatic or non-enzymatic), within the 
enzymatic digestion, in the type and concentration of the enzyme used, time and 
conditions of incubation for tissue digestion, time and parameters of centrifugation, 
number of filtration used and methods of cell culture [37]. 
The first study that was aimed to isolate cells from adipose tissue was performed by 
Rodbell [51]. In that study, epididimal fat pads of rats were used, that were washed 
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and incubated with collagenase and centrifuged to separate the floating population of 
mature adypocites from the pelleted stromal vascular fraction (SVF) [36]. 
The most commonly used procedure to isolate the SVF from adipose tissue samples, 
obtained by biopsy or liposuction, is the enzymatic method (see Figure 3). Firstly, it is 
necessary to wash the tissue repeatedly with sterile PBS or culture medium. After, the 
tissue sample is minced using scalpels and a collagenase solution is used to incubate 
the sample at 37ºC, 5% CO2 for 30 minutes to one hour, with agitation. After that time, 
the collagenase is neutralized with culture medium, and the sample is pipetteed up 
and down to facilitate the disintegration of the tissue. The digested tissue is following 
centrifuged so that the separation of the stromal cells from the primary adipocytes is 
conducted [22], [36], [37], [52]–[54]. 
The centrifugation results in the separation of the sample from adipose tissue into 
three distinct layers (Figure 2): infranatant (bottom layer), middle portion and 
supranatant (upper layer). The infranatant contains blood, the SVF, fluid tissue and 
local anesthetic (in case of liposuction from human adipose tissue); the middle portion 
is composed primarily by fatty tissue; and the supranatant consist in lipids from fat 
cells [55]. 
 
Figure 2 Schematic of tube appearance after centrifugation, conducted to obtain the stromal vascular 
fraction which contains the mesenchymal stromal cells 
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Then, the attained cell pellet within the infranatant can be resuspended in lyses buffer, 
incubated on ice, washed and centrifuged. The attained single-cell cell suspension can 
be resuspended in culture medium and filtered through strainer (Figure 3). The 
adipose derived stromal cells are isolated and ready to be cultured in a suitable 
medium and substrate  [22], [36], [56]. 
 
 
 
Figure 3 Procedure for isolation of ASCs from adipose tissue (adapted from (21)) 
 
Although, the enzymatic digestion is the most used isolation technique, there are some 
disadvantages reported in literature [57]–[61]. Enzimatic digestion is time consuming 
(between 30 minutes to 1 hour), expensive due to the cost collagenase, decreases cell 
viability due to lytic activity and ineffective when applied to large volumes of tissue 
[57]–[61]. 
Another problem in the traditional methods of isolation is the contamination of 
adipose tissue samples with other types of cells, due to the inefficient isolation 
procedure [58]. To solve this, new methods (enzymatic, non-enzimatic and mechanical 
techniques) are being developed to improve isolation [57]–[60].  
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Another factors that can influence the cell yield, growth and frequency, and which are 
described in the literature, include: the type of surgery used for adipose tissue 
harvesting (resection, tumescent liposuction and ultrasound-assisted liposuction) [62]; 
the harvest site [63]–[70]; donor age  [3], [69], [71]; body mass index [3], [72]; isolation 
processes (like decantation, washing and centrifugation) [73]; the instruments used to 
collect the adipose tissue during the liposuction (for instance the size of liposuction 
cannula [56]); culture procedure (initial plating density and confluence, composition of 
cultured basal media, cell culture supplements, addition of antibiotics, oxygen supply 
and method of subculturing [3]). 
While literature reports seem to converge to an agreement on some of these 
parameters, conflicting data is reported on the evaluation of other parameters. Some 
examples are following given.  
In a study that compares biopsies of adipose tissue from different anatomical sites in 
rats,  it is suggested that ASCs from the neck region seem to be the best source for 
regeneration of nervous tissue  [64]. The study from Jurgens et al., intended to 
understand whether the yield of ASCs are affected by the anatomical sites, reported 
that the abdomen seems to be preferable to the hip/thigh region for harvesting 
adipose tissue [65]. 
Schipper et al. [63] evaluated the age of donors and concluded that results are 
dependent on donor age  and the younger age range tended to have the highest 
activity in each subcutaneous depot [63]. Mojallal et al. [71] examined adipose tissue 
samples from 42 women divided into 2 groups according to BMI (body mass index), 
and concluded that there is no significant correlation between ASC yield and 
proliferation capacity, and age and BMI [71]. The same result was obtained by 
Buschmann et al.[69], which concluded that BMI do not influence cell yield and 
proliferation rate. However, Harmelen et al. concluded that the capacity of stromal 
cells appears to decrease with increasing BMI [72]. Frazier et al. [74] also concluded 
that a elevated BMI resulted in reduced ASC proliferation and osteogenic 
differentiation in vitro. 
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Relative to the size of liposuction cannula, it is generally accepted by researchers to 
have influence in cell viability, since an increase in the diameter, corresponds to an 
increase in the cell viability [55], [56].  
The basal medium for ASCs cultures also seems to influence the proliferation and 
differentiation capacity [3]. Most laďoƌatoƌies use the DulďeĐĐo͛s ŵodified Eagle 
medium (DMEM) as a basal medium to culture ASCs, but there are different 
concentrations and components commercially available. ASCs cultivated in DMEM with 
a higher glucose concentration seems to present the best proliferation rate [3], despite 
that a low calcium concentration together with antioxidants has also been show to 
accelerate the proliferation of ASCs [75]. Another study that compared different types 
and concentrations of basal media concluded that Minimum Essential Medium Eagle 
ǁith the alpha ŵodifiĐatioŶ ;α-MEM) allowed a significantly faster cell expansion than 
the other media used in researcher [76].  
Another issue that has been discussed is the use of autologous serum, serum-free 
cultures supplemented with platelet-derived supplements [77] or growth factors, 
instead of the routine use of fetal bovine serum (FBS) [78]–[81]. The culture medium 
for ASC proliferation and expansion requires supplementation with serum. The main 
function of serum in culture is to provide hormonal compounds which stimulate cell 
growth and proliferation providing transport proteins, minerals, lipids, attachment and 
spreading factors [81]. The most used is fetal bovine serum, however the use of 
xenogeneic serum can cause several problems, namely induction of immune reactions 
and viral or bacterial infections [78], [79], [81]. The conclusions of studies that 
analyzed the behavior of ASC cultured in autologous serum, showed that ASCs can be 
efficiently propagated without the loss of specific markers and multipotency [79]. 
Autologous serum was found to be used as a culture medium supplement that 
adequately supported the expansion of ASCs [77], [82]. Within the translation of the 
clinical scenario, the human platelet lysate has also been study to substitute FBS, and 
shown to be effective in growth and expansion of ASCs, minimizing the risk of 
microbial infections and reducing the immunological reactions  [77], [82]. 
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DIFFERENTIATION OF ADSCS    
Adipose stromal cells show multipotency, that is, they retain the ability to differentiate 
into cell types of multiple different lineages. They can differentiate into classical 
mesenchymal lineages (adipogenic, chondrogenic, osteogenic and myogenic). The 
differentiation of these cells can be directed by the addition of specific combinations 
of chemical compounds or cytokines  to the culture medium [36]. 
Adipogenic differentiation can be induced using culture medium supplemented with 
isobutylmethylxanthine, indomethacin and dexamethasone [36]. The accumulation of 
neutral lipids can be detected by staining the cells in a solution of Oil Red  [36] and the 
ASCs in culture expresses several adipocytic genes including lipoprotein lipase, aP2, 
PPA‘γ, leptiŶ, Glutϰ, aŶd lipid-laden intracellular vacuoles [17], [38]. 
The induction of osteogenic differentiation is promoted by supplementation of the 
medium with dexamethanose, beta-glycerol-phosphate and ascorbic acid [22], [36]. 
The concentrations of these inductors is not consensual, because the traditional 
osteogenic medium used was optimized for differentiation of bone marrow stromal 
cells and may not be optimal for differentiation of ASCs  
To address the osteogenic differentiation, extracellular matrix calcification can be 
confirmed by von Kossa or Alizarin red staining, and alkaline phosphatase activity may 
be measured biochemically or following histochemical staining  [22]. Cells can also be 
examined by PCR techniques for the expression of several osteogenic-specifc genes, 
including osteocalcin, run-related transcriptional factor 2 (Runx-2), osteopontin, 
ostenectin, bone morphogenetic protein (BMP-2) and, also, for the receptors involved 
iŶ osteogeŶesis ;paƌathǇƌoid hoƌŵoŶe ƌeĐeptoƌ/PTH‘, ‘X‘α aŶd ǀitamin D 
receptor/VDR) [17]. ASCs in culture, following osteogenic differentiation, express 
genes and proteins associated with an osteoblasts phenotype, including alkaline 
phosphatase, type-I collagen, osteopontin, osteonectin, osteocalcin, bone sialo 
protein, RunX-1, BMP-2, BMP-4, BMP receptors I and II, PTH-receptor (37). 
For chondrogenic differentiation, micromass culture techniques and cell pellets are 
cultured with bone morphogenic proteins, dexamethasone, ascorbate-2-phosphate 
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and insulin  [22], [36]. Chondrogenesis can be confirmed by using the histological stain 
Alcian Blue at acidic pH [22]. Following specific induction, ASCs produce large amounts 
of cartilage-related extracellular matrix molecules, including sulfated proteoglycans, 
collagen II and IV  and aggrecan [38]. 
Myogenic differentiation can be induced by dexamethasone, hydrocortisone and 
azacytidine  [22], [38], and confirmed by immune-histochemical staining for the 
muscle-specific transcription factor (MyoD1) and the myosin heavy chain [22]. 
Following induction, cells show a pattern of expression of muscle-related genes that is 
consistent with normal myogenesis, with the expression of regulatory factors MyoD1, 
myf5, myf6 and myogenin. Morphologically, they are similar to the muscle cells, 
becoming long and multinucleate [38]. 
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THREE-DIMENSIONAL CULTURE OF ADSCs 
Three-dimensional (3D) cultures systems allow an increased cell-to-cell interactions 
and mimics more closely the physiological conditions between the cells and the 
extracellular matrix, when compared with two-dimensional cell culture techniques 
(monolayer cultures) [83]–[88]. 
Traditionally, 3D cell aggregates or spheroids have been used to study the behavior of 
tumor cells but also study biological mechanisms, angiogenesis, immune response, 
mimic embryogenesis in stem cell culture and induce clonal propagation and 
spontaneous differentiation [89]–[93]. 
In the literature, there are several techniques used to generate spheroids, but the 
common principle of all methods is preventing the cellular attachment to a culture 
substrate [83]–[88].  
The hanging-drop technique (HDT) is based on the deposition of a droplet of cells onto 
the underside of the lid of a tissue culture dish. After, the lid is inverted on the lower 
half of the dish, and the drops are maintained on the lid by surface tension, since the 
cells cannot adhere on the air-liquid interface occurring, the spheroids form 
spntaneously [83], [86]. The HDT is simple to perform, inexpensive and allow the 
geŶeƌatioŶ of spheƌoids ǁith defiŶed sizes, Đell Ŷuŵďeƌs aŶd ĐoŵpositioŶ. But it͛s 
difficult at large scale production  [86] and long term culture [94]. 
The liquid overlay technique (LOT) uses a non-adhesive surface to prevent the cellular 
adhesion [83], [86], [89]. These non-adhesive surface can be achieved by coating the 
bottom of the plate with agarose or hydrophobic polymers [83], [86], [89]. The 
disadvantage of this technique is the variation in size, cell number and shape; however 
it͛s siŵple to peƌfoƌŵ, iŶeǆpeŶsiǀe aŶd easǇ to sĐale up [86]. 
Another method to generated spheroid is to use spinner flasks and roller bottles. If the 
cells are maintained in motion using a gyratory rotation incubator, they cannot adhere 
to surface and they will form spheroids [83], [86], [89]. With this teĐhŶiƋue it͛s possiďle 
generated spheroids in a large scale, in a simple way and with a dynamic control of 
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culture condition [86]. But, it͛s necessary specialized equipment and the spheroids 
generated have variations in size and cell number [86]. 
Spheroids can also be generated using conical plastic tubes. After isolation, the cells 
are subject to a centrifugation and the resulting cell pellet is left in the conical plastic 
tubes [83], [95], [96]. The tubes should be shaken in certain periods of time to avoid 
the pellet sedimentation [96]. 
Like another type of cells, mesenchymal stromal cells and namely adipose-derived 
stƌoŵal Đells ;AD“C͛sͿ haǀe the aďilitǇ to foƌŵ ŵultiĐellulaƌ spheƌoids ǁithout a 
scaffold [85], [88], [91], [94]. 
Apart from the scaffold-free techniques previously described, several 3D scaffolds can 
be used to provide physical support for cell self assembly and any external forces that 
enhance rapid cell aggregation, like low-speed centrifugation, magnetic fields and 
ultrasound standing wave traps, can be used in association [86]. 
The microenvironment generated in 3D culture systems mimic the stromal cell niche in 
vitro, improving the intercellular adhesion, the extracellular matrix interaction, 
proliferation and differentiation [94].   
Hildebrandt el al. [94] compared three different techniques to generated multicellular 
aggregates of human bone marrow mesenchymal stromal (hBMSCs) cells considering 
the differentiation into osteogenic lineage. The techniques used were the hanging 
drop method combined with suspension culture, the plastic tube culture and liquid 
overlay technique (LOT). They concluded that the cultivation of hBMSCs in 96 well non 
adhesive plates was the best method since the formed aggregates were uniform, the 
efficiency was good and the osteogenic capability was induced [94]. 
In the work of Baraniak et al.  [91], mice BMSCs spheroids were formed using a forced 
aggregation technique. The goal was understand the behavior of the spheroids in long 
periods of time taking into account differentiation potential and the multipotency of 
the cells [91]. They demonstrated that the mesenspheres formed exhibited the ability 
to differentiation into osteogenic and adipogenic lineage and maintained under 
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growth conditions for a long time (16 days). Moreover, the development of 3D culture 
allow control several critical parameters that can used to generate an in vitro model 
for the study of cell-cell and cell-matrix interactions. 
Kapur et al. [88] using a hanging-drop technique formed human ADSCs spheroids with 
different cell concentrations and in different types of culture medium, to optimize the 
method and establish the best conditions. The spheroids formed showed ability to 
proliferate, renewal and differentiate in different culture medium used and the 
techniques applied in spheroids formation demonstrate reproducibly and efficacy [88]. 
Shen et al. [87] made an in vitro and in vivo study to characterize the osteogenic 
differentiation of human ADSCs aggregates. The technique used to generate the 
spheroids was the hanging drop and the differentiation was proven using histology and 
gene expressing. The in vivo assay consisted in implantation of human ADSC spheroids 
alone, Matrigel with human ADSCs and Matrigel alone (control) in a rat muscle pouch. 
Furthermore, they reseed the ASC spheroids onto monolayer culture to investigate the 
potential of proliferation and differentiation. The results showed that spheroids 
maintained the renewal potential and multilineage differentiation capabilities [87]. 
Lashke et al. [85] using the LOT technique generated ADSC spheroids to analyze the 
angiogenesis mechanism. The ADSC spheroids were incorporated into polyurethane 
scaffolds and a dorsal skinfold chamber model was used, as an in vivo assay. They 
conclude that ADSCs spheroids enhanced the blood vessel formation being suitable for 
tissue engineering applications [85]. 
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ADSCs IN REGENERATIVE MEDICINE APPLICATIONS 
Tissue engineering and regenerative medicine are two fields of science that combine 
tools of medicine and engineering, by acting on cells, growth factors and biomaterials, 
in order to enhance the tissue formation and regeneration, repair or maintenance of 
the physiological function of a tissue or organ [2], [97], [98]. 
Mesenchymal stromal cells (MSCs) in general, show a huge potential therapeutic 
activity that may be used in a wide range of diseases. The main reasons for the use of 
MSCs in tissue engineering and regenerative medicine are: the ease of isolation and 
expansion, high expansion potential, ability to differentiate into several mesodermal 
lineages, paracrine effects that modulate the host cells, multipotency, 
immunomodulatory properties, migratory behavior and ethical considerations [5], [7], 
[37], [43], [85]. Particularly, the adipose stromal cells (ADSCs) have generated a great 
deal of interest since they are relatively accessible [2]; the enzyme-based isolation 
procedures are uncomplicated [99] and they can be isolated in large quantities, and 
hold no ethical concerns [3]. 
Once ADSCs have the ability to differentiate into bone, cartilage, skeletal muscle and 
fat, the tissue engineering of mesenchymal organs is the main purpose [99]. The 
clinical application may include, for example, repair of soft tissue defects (owing to 
traumatic injury, tumor resection and congenital defects) [100], cartilage repair in the 
joints, skeletal regeneration after tumor or trauma, repair of bone defects, etc  [99]. 
Further, other applications include the use of ASC sthrough a paracrine effect. For 
instance, improve the myocardium function after infraction, possibility peripheral 
nerve regeneration, hepatic regeneration, insulin-producing islet cell regeneration and 
recovery of renal function, have been considered [55]. Accordingly, the potential of 
ADSCs for regenerative medicine is related to their differentiation ability, but also due 
to their paracrine and thropic effects [40], [101] and their immunomodulatory 
properties [97], [102]. 
Unlike the BMSCS, the immunosuppressive properties of ADSCs have not been studied 
adequately [97]. However, several studies have shown that ASCs exert 
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immnomodulatory and protective effects on graft-versus-host response, inhibiting the 
production of inflammatory cytokines, stimulating the production of anti-
inflamatory/suppressive cytokines, such as IL-10, by monocytes and T cells. Further, 
they have been shown to induce the generation of antigen-specific regulatory T cells 
and to inhibit the lymphocyte proliferation [97], [98]. Moreover, ADSCs seem to be 
immunopriviledged due to lack of HLA expression (major histocompatibility complex 
class II antigens) [97]. 
Another featuƌe of AD“Cs is the ĐapaĐitǇ to aĐt as ͞seĐƌetoŵe͟ [97], [98], [102]. In this 
context, ADSCs secrete proteins and growth factors into the extracellular milieu that is 
able to influence and modulate other cells and tissues [98], [102]. The molecules which 
can be related to this modulatory activity of ADSCs are, for instance,  adiponectin, 
angiotensin, cathepsin D, penetraxin, pregnancy zone protein, retinol binding protein, 
hepatocyte growth factor, granulocyte and macrophage colony stimulating factors, 
tumor necrosis factor-alpha, vascular endothelial growth factor, brain derived 
neurothopic factor, nerve growth factor, adipokines, among others [98]. Many studies 
have tried to understand the beneficial effect of ADSC in non-mesodermal tissues 
ďased oŶ  ͞seĐƌetoŵe͟ effeĐt  aŶd iŵŵuŶoŵodulatory activity [102]. These studies 
included applications on tissue regeneration and repair on the central nervous system, 
immune system, heart and muscle  [102]. 
Despite all the investigation and research carried out in the field of adipose 
mesenchymal stromal cells, an optimized procedure for cell harvest and expansion is 
still lacking, as well the definition of several parameters to optimize the isolation of 
ADSCs and, consequently, the cell culture and their use in a regenerative therapy.  
One of the factors than is expected to significantly influence the cell proliferation and 
differentiation is the location of tissue harvest. Accordingly, in order to disclose this 
effect for prospective translational use of ADSCs in regenerative medicine applications, 
particularly focusing on the bone tissue, this work aims the evaluation of the cell 
behavior of osteogenic-induced ADSCs, harvested from different anatomical locations 
within the rat.  
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RESEARCH HYPOTHESIS  
It was hypothesized that adipose-derived stromal cells harvest from different 
anatomical locations showed a distinct functional activity, particular regarding cell 
proliferation and ostegenic differentiation capacity. 
OBJECTIVES  
This work aimed the isolation of ADSCs from distinct anatomical locations and the 
characterization of the osteogenic differentiation capability of these cells.  
Specific objectives included: 
- isolation of stromal cells from the adipose tissue harvested from different 
anatomical locations (subcutaneous inguinal, abdominal inguinal, flank, neck 
and omentum) within the rat; 
- establishment  of a two-dimensional culture (monolayer) of osteogenic-induced 
ADSCs; 
- establishment of a three-dimensional  culture (spheroids) of osteogenic-
induced ADSCs; 
- characterization of the established cultures through biochemical, 
histochemical, gene expression and microscopical techniques. 
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MATERIALS 
All cell culture chemicals and supplies were acquired from Merck and Sigma Aldrich (St. 
Louis, MO) unless otherwise noted. All tissue culture flasks and plates were obtained 
from Corning (Corning, NY).  
METHODS 
ANIMALS  
In this study, twelve female Wistar rats (Charles River, Wilmington, MA), 7-8 weeks 
old, with a body weight of around 250-300g, were used.  Animals were housed in type 
II plastic cages, in a monitored environment of temperature and humidity, in a 12h 
light/dark cycle. Dry feed and water was supplied ad libitum. 
ISOLATION OF ADIPOSE-DERIVED STROMAL CELLS (ADSCS) 
After the euthanasia of the animals, the adipose tissue was harvested in two different 
ways: removing fat from undifferentiated anatomical locals (FUAL) and fat from 
differentiated anatomical locals (FDAL). The sites were chosen taking into account 
previously literature reports and these included: abdominal inguinal area, flank, neck, 
subcutaneous inguinal area and omentum (see Figure 4). 
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Figure 4 Different anatomical locals of fat harvest with respective harvest tissue aside. A – 
subcutaneous inguinal; B – abdominal inguinal: C – omentum; D – neck; E – Flank. * marks the specific 
site of harvest. 
 
In  these experimental procedures, large pieces of harvested fat were cut into very 
small pieces (around 1mm
3Ϳ aŶd plaĐed iŶ a deĐoŶtaŵiŶatioŶ solutioŶ ĐoŶsistiŶg of α-
MiŶiŵal EsseŶtial Mediuŵ ;α-MEM) supplemented with 2.5µg/ml fungizone (Fungi.) 
and 100 IU/ml penicillin-2.5µg/ml streptomycin (Pest.) for about one hour. 
After this time, the adipose tissue sample was placed in a propylene tube with 0.075 
ŵg/ŵl ĐollageŶase tǇpe IA iŶ α-MEM  for tissue digestion, which was incubated for one 
hour at 37ºC, 5% CO2 in air, with periodic stirring to facilitate the digestion. 
Afterwards, the collagenase activity was neutralized by adding of 10% of fetal bovine 
serum (FBS) and the cell suspension was filtered and transferred to another propylene 
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tube. Then, the samples were centrifuged at 1200 rpm for 10 minutes and a separation 
into distinct layers was obtained, with the last layer (the pellet) corresponding to 
stromal vascular fraction (SVF) (see Figure 5). 
 
 
Figure 5 Schematic representation of the isolation method used to obtain the adipose-derived stromal 
cells from SVF 
 
The cell pellet was resuspended iŶ Đultuƌe ŵediuŵ ;α-MEM supplemented with 10% of 
FBS, Fungi, Pest and 5 mg/ml of ascorbic acid (AA)) and seeded in a 6-well plates ( 9 
cm
2
 area). The culture medium was changed the next day, and following, every 2/3 
days, and the cultures were regularly observed by contrast phase microscopy.   
MONOLAYER CULTURE (2D) 
ADSCS  from fat from undifferentiated anatomical locals ( FUAL) 
The primary culture took seven days to achieve a state of around 80% confluence. On 
this day the first sub-culture was established, as follows. Cells from primary cultures 
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were obtained by tripsinization (trypsin 0.04%) , the cellular viability was assessed by 
the exclusion method of blue trypan and following, cells were counted in a Neubauer 
Improved Chamber. The cells were seeded in 96-well plates (0.32 cm
2
 area) at a 
density of 10
4 
cells/cm
2
.  
Cells were cultured in three different conditions: the control medium (CM) – α-MEM 
with 10% FBS, 2.5µg/ml of Fungi, 100 IU/ml penicillin-2.5µg/ml streptomycin and 5 
mg/ml of AA - osteogenic medium 1 (OM1) -  α-MEM with 10% FBS, 2.5µg/ml of Fungi, 
100 IU/ml penicillin-2.5µg/ml streptomycin and 5 mg/ml of AA  and dexamethasone 
10
-6
 M– and osteogenic medium 2 (OM2) - α-MEM with 10% FBS, 2.5µg/ml of Fungi, 
100 IU/ml penicillin-2.5µg/ml streptomycin and 5 mg/ml of AA  and dexamethasone 
10
-6
 M aŶd β-glicerol-phosphate 1M. Cultures were maintained during 15 days. The 
culture medium was renewed 2-3 times per week and cultures were analysed at 
adequate time points.  
ADSCS from fat from differentiated anatomical locals (FDAL) 
The primary culture took eight to ten days to achieve a state of around 80% 
confluence. On this day, cells from primary cultures were obtained by tripsinization 
(trypsin 0.04%), the cellular viability was assessed by the exclusion method of blue 
trypan and following cells were counted in a Neubauer Improved Chamber and seeded 
in 96-well plates (0.32 cm
2
 area), at a density of 5x10
3 
cells/cm
2
.  
Each anatomical local was subject two different experimental conditions: control 
medium (CM) and osteogenic medium 2 (OM2) with the previously described 
compositions. The cultures were maintained during 15 days, the culture medium was 
renewed 2-3 times per week and cultures were analyzed at adequate time points. 
Characterization of cell cultures  
To characterize the established cell cultures biochemical methods were used, 
including, quantification of DNA, MTT assay, quantification of alkaline phosphatase 
activity, histochemical methods for the staining of alkaline phosphatase activity, 
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collagen and senescence-associated beta-galactosidade activity, microscopic 
techniques and gene expression analysis. 
 Optical microscopy 
Monitorization of cell cultures was conducted periodically through observation by 
phase contrast microscopy to adress the morphology and proliferation. 
Assessment of the cell proliferation  (DNA quantification) 
The DNA quantification was performed using PicoGreen®. PicoGreen® is an ultra-
sensitive fluorescent nucleic acid stain for double-stranded DNA quantification. When 
this dye was added to the samples it blended with the double-stranded DNA and the 
fluorescence emitted could be measured: it had a maximum excitation at 480 nm and 
an emission peak at 520 nm [103]–[105]. 
On the day of the experiment, after removing the culture medium, the cells were 
washed twice with PBS aŶd ϭϬϬμL of TƌitoŶ X-100 0,1% were added to each well. The 
plates were incubated during 45 minutes at room temperature.  
During this time, the PicoGreen® solution was prepared. For this purpose, PicoGreen® 
was diluted in 1X-TE buffer. Posteriorly, diluted PicoGreen was added to the samples 
which were in a black 96-well plate. The fluorescence was measured in an ELISA plate 
reader (Synergy HT BioTek) with excitation at 480nm and emission at 528 nm. 
Assessment of  the metabolic activity (MTT assay)  
The  MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is a 
colorimetric assay to assess the metabolic activity of viable cells, which can be useful in 
the indirect evaluation of cytotoxicity, cell viability and proliferation [106]. When 
added to the cells, MTT was reduced by the activity of mitochondrial dehydrogenases 
and the reducing agents present in metabolically active cells, originate dark colored 
formazan salts that are insoluble in aqueous solutions (see Figure 6) [106]. The lipid 
soluble formazan crystals can be dissolved in an organic solvent, like dimethyl 
sulphoxide (DMSO) and the optical density measured on a multiwall 
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spectrophotometer [106], [107]. The amount of MTT formazan measured is directly 
proportional to the number of metabolically active cells [108], [109]. 
 
 
Figure 6  Chemical structure of MTT and reduction to formazan product (adapted from (105)). 
 
The MTT analyses were conducted at specific time points. On each of these daǇs, ϭϬμL 
of MTT were added to each well and incubated for 2 hour at 37ºC with 5% CO2. Then, 
the ŵediuŵ ǁas ƌeŵoǀed aŶd ϭϬϬμL of DM“O ǁeƌe added. The aďsoƌďaŶĐe ǁas 
measured at 550 nm in an ELISA plate reader (Synergy HT BioTek). 
Assessment of Cell Morphology 
Established cell cultures were characterized by confocal laser scanning microscopy 
(CLSM) following staining of cytoskeleton and nucleus counterstaining. For CLSM 
assessment, cell cultures were fixed in 3.7% paraformaldehyde during 15 minutes and 
permeabilized with Triton X-100 (0.1%). Then cells were incubated with albumin (10 
mg/ml) to reduce non-specific staining. Cell cytoskeleton filamentous actin (F-actin) 
was visualized treating the cells with Alexa Fluor 488®-conjugated phalloidin (1:20 
dilutioŶ iŶ PB“ foƌ ϮϬ ŵiŶutesͿ aŶd ĐouŶteƌstaiŶed ǁith pƌopidiuŵ iodide ;ϭ μg/ŵl foƌ 
10 min) for cell nuclei labeling. Labeled cultures were mounted in Vectashield® and 
examined with a Leica SP2 AOBS (Leica Microsystems) microscopy. 
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Assessment of the alkaline phosphatase activity 
Alkaline phosphatase (ALP) is a metalloenzyme present in various tissues, including 
bone. In bone, ALP is produced by osteoblasts and serves as an indicator of their 
activity, being considered a marker of earlier osteogenic differentiation in vitro [110], 
[111]. 
The presence of this enzyme is detected by using a specific substrate, the p-
nitrophenylphosphate (pNPP). In a buffered solution, and at alkaline pH, the hydrolysis 
of pNPP occurs mediated by ALP, resulting in p-Nitrophenol (yellowish compound) and 
a phosphate group, according to the following reaction [112]–[114]: 
 
Figure 7 Reaction of pNPP hydrolysis to form p-nitrophenol and phosphate 
 
The amount of p-Nitrophenol formed is determined by the absorbance at a specific 
wavelength (the value is around 400nm). The quantity generated is proportional to the 
ĐoŶĐeŶtƌatioŶ of ALP pƌeseŶt iŶ saŵple, aĐĐoƌdiŶg to Beeƌ͛s laǁ [115]. 
After removing the culture medium, the cells were washed twice with PBS 
;Phosphatase Buffeƌed “aliŶeͿ. TheŶ, ϭϬϬμL of TƌitoŶ X-100 0,1% were added to each 
well and the plates were incubated at room temperature during 45 minutes. After that 
time, the buffered substrate was prepared (this is, p-NPP in alkaline buffer solution), 
added to the samples and incubated for 1 hour at 37ºC with 5% CO2 in air. To stop the 
ƌeaĐtioŶ, ϮϬ μL of NaOH ϱM ǁeƌe added aŶd the aďsoƌďaŶĐe ǁas ŵeasured in an ELISA 
plate reader (Synergy HT BioTek) at 400nm.  
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Histochemical methods 
The cell cultures were fixed on specific time points for subsequent realization of 
histochemical assays, namely the staining of alkaline phosphatase, staining of collagen 
and senescence staining. The culture medium was removed and all wells were washed 
twice with PBS. The cells were treated with glutaraldehyde at 1.5% during 10 minutes 
and, thereafter, the cells were maintained in sodium cacodylate buffer 0,14M and 
conserved at 4ºC. 
Staining of alkaline phosphatase activity 
The staining of alkaline phosphatase is based in hydrolysis of sodium phosphate 
naphthyl (Na-α-ŶaphtǇlͿ. The phosphate foƌŵed ƌeaĐts ǁith a diazoŶoŶiuŵ salt ;͞Fast 
Blue ‘‘ “alt͟Ϳ aŶd forms a colored precipitate [116], [117]. The staining intensity 
depends on the activity of the alkaline phosphatase enzymes present on cells, and 
varies between light brown to black. 
In the present work it was prepared a Tris buffer solution 0,1M with 2mg/mL of Na-α-
naphtyl phosphatase and 2mg/mL of Fast Blue RR Salt complex. This solution was 
added to the culture that was previously fixed. After spending an hour in the dark, 
samples were washed with distilled water and air-dried. Stained cultures were 
photographed in a Nikon TMS Inverted Phase Contrast microscope with magnifications 
of 40x and 100x. 
Staining of total collagen content 
The staining of collagen is based in the interaction of a strong anionic dye, called Sirus 
Red, with collagenous fibrils. This dye stains collagen through a reaction of its 
sulphonic acid groups with basic groups present in the collagen molecule [118]. 
After removing the buffer, 100µL of Sirus Red dye were added to each well.  An hour 
was waited for the dye to react and, after that, the samples were cleaned with 
hydrochloric acid 0.01N, in order to clean all the excess dye. Stained cells cultures were 
photographed in a Nikon TMS Inverted Phase Contrast microscope with magnifications 
of 40x and 100x. 
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Staining of senescence-associated beta-galactosidade activity   
Senescence-associated beta-galactosidade (SA-βgalͿ is aŶ hǇdƌolase eŶzǇŵe that is 
only present in senescent cells [119]–[121]. 
The principle of the assay is based on cleavage of the chromogenic substrate 5-bromo-
4-chloro-3-iŶdoǇl β-D-galactopyranoside (X-galͿ ďǇ β-galactosidade, that following 
reaction yealds blue precipitate [119], [121].  
This staiŶiŶg ǁas ŵade usiŶg the ͞“eŶesĐeŶĐe Cells HistoĐheŵiĐal “taiŶiŶg Kit͟ fƌoŵ 
Sigma Aldrich. After removing the fixation fluid, the cells culture were washed twice 
with warm PBS and 50µl of staining mixture (that contains, among others, the X-gal 
solution) was added to each well.  Then, the culture was incubated overnight at 37ºC 
without CO2 (120). Stained cultures were photographed in a Nikon TMS Inverted Phase 
Contrast microscope with magnifications of 40x and 100x. 
 Gene Expression Analysis  
Reverse-transcription polymerase chain reaction (RT-PCR) analysis was done in the 
ADSCS from FUAL and FDAL at specific time points. All were evaluated for the 
expression of Run-related transcription factor-2 (RUNX-2), Peroxisome proliferator-
actived receptor gamma (PPAR-γͿ, “oǆ9, MǇoD aŶd GlǇĐeƌaldehǇde ϯ-phosphate 
dehydrogenase (GAPDH). The primers used are listed on Table 1. The total RNA was 
extracted using the NucleoSpin® RNA II Kit (Macherey-Nagel) according to the 
ŵaŶufaĐtuƌeƌ͛s iŶstƌuĐtioŶs. The ĐoŶĐeŶtƌatioŶ aŶd puƌitǇ of total ‘NA iŶ eaĐh saŵple 
were assessed by UV spectrophotometry at 260 nm and by calculating the 
A260nm/A280nm ratio, respectively. RT-PCR was done using the Titan One Tube RT-
PC‘ sǇsteŵ ;‘oĐhe® Applied “ĐieŶĐeͿ, aĐĐoƌdiŶg to the ŵaŶufaĐtuƌeƌ͛s iŶstƌuĐtioŶs, foƌ 
30 cycles. RT reaction mixtures consisted of extracted RNA, Titan RT-PCR buffer, 
dithiothreitol (DTT), deoxynucleoside triphosphate (dNTP), primers for each tested 
geŶe aŶd ǁateƌ, iŶ a total ǀoluŵe of Ϯϱ μl. Total ‘NA ǁas ƌeǀeƌse tƌaŶsĐƌiďed ǁith 
cDNA (30 minutes at 50ºC), which was then amplified with recombinant Taq- DNA 
polymerase at different annealing temperatures. For all the genes, the annealing 
temperature was 55ºC. The PCR products were electrophoresed in a 1% agarose gel, 
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stained with ethidium bromide and semi-quantitatively assessed by densitometry with 
Image J® software (US National Institutes of Health) version 1.37. The data were 
expressed as normalized ratios by comparing te integrated density values for all tested 
genes with those for GAPDH.  
 
Table 1 Primers used on RT-PCR analysis 
 
 
SPHEROID FORMATION AND 3D CULTURES  
The technique used to formed the ADSCS spheroids was the liquid overlay [83], [84]. 
First, an 1% of agarose solution (Seakem LE Agarose, Lonza) was prepared in destiled 
water and sterilized by autoclaving. After melt in microwave, 50 µl of liquid agarose 
was placed in the bottoms of 96-well plates. This coating avoids the cell adhesion 
allowing the spontaneous spheroid formation. 
ADSCS from fat from undifferentiated anatomical locals (FUAL) 
For this experiment, the ASCs isolated were seeded in two plates with 58 cm
2 
of area. 
After eight days, the cells reached the adequate confluence (around 80%) and were 
trypsinized (trypsin 0.04%). The cellular viability was assessed by the exclusion method 
of blue trypan followed by cell quantification in a Neubauer Imporved Chamber. 
The cells were seeded in 96-well plates (0.32 cm
2
 area) previously coated with 1% of 
agarose solution, at two different densities:  5x10
4 
cells/cm
2 
and 20x10
4
 cells/cm
2
.  For 
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each seeding density 16 wells were prepared and the spheroids were subjected two 
different experimental conditions: control medium (CM) and osteogenic medium 
(OM2) with the compositions previously described.  
After 24 hours of incubation at standard conditions, the formation of spheroids was 
verified by optical microscopy and formation efficiency (ratio between obtained 
aggregates and initial number of seeded aggregates) was determinate. Cultures were 
maintained during 17 days and, twice a week, half of the culture medium was 
renewed. The maintenance rate (M.R.), consisting in the number of spheroids during 
the days of culture in relation to the number of formed aggregates at 24 hours, was 
measured. 
ADSCS from fat from differentiated anatomical locals (FDAL) 
Isolation of adipose tissue was conducted as previously described. Following, first 
subcultured cells were seeded in 96-well plates (0.32 cm
2
 area) previously coated with 
1% of agarose solution at a density of 20x10
4
 cells/cm
2
.  For each anatomical location 
32 wells were prepared and the spheroids were subjected two different experimental 
conditions: control medium (CM) and osteogenic medium (OM2) with the 
compositions previously described. 
After 24 hours of incubation at standard conditions, the formation of spheroids was 
verified by optical microscopy and the formation efficiency was determined (ratio 
between obtained aggregates and initial number of seeded aggregates). On day 6, the 
maintenance rate (M.R.) of spheroids was measured in different anatomical locals. 
Cultures were maintained during 9 days and twice a week, half of the culture medium 
was renewed. 
Image analysis 
At specific time points, spheroids from FUAL and FDAL were photographed in a Nikon 
TMS Inverted Phase Contrast microscope with magnifications of 40x and 100x. 
The microscopic images were analyzed to quantify the size of the spheroid in terms of 
cross-sectional area using Image J® software (US National Institutes of Health) version 
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1.37. The cross-sectional area was measured automatically using the appropriate tools 
from the software used. 
STATISTICAL ANALYSIS  
The data presented within this work is the result of 3 separate experiments. 
Multivariate analysis of variance (MANOVA) was conducted and no significant 
differences were verified between experimental settings. Accordingly, the shown 
results, are the ones from a representative experiment.  Further, within quantitative 
data (MTT assay, ALP activity, DNA and PCR gene expression) each point represents 
the mean values  ±  standard error and for cross-section area of evaluated spheroids, 
each point represent mean values ± standard deviation. For quantitative assays, 5 
replicates except where otherwise noted were conducted. Qualitative analysis and 
microscopical evaluation were conducted in triplicates. Statistical analysis was done by 
t-student test iŶ the softǁaƌe EǆĐel. P ǀalues ≤Ϭ.Ϭϱ ǁeƌe ĐoŶsideƌed sigŶifiĐaŶt. 
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Characterization of the two-dimensional ADSC cultures 
(monolayer) 
ADSCS FROM FUAL  
Cells were cultured in control medium during the primary culture (Figure 8) and the 
first subcultures were evaluated for cell morphology, proliferation, viability and 
osteoblastic differentiation, following specific induction, during 15 days.  
Cultuƌes estaďlished iŶ the aďseŶĐe of osteogeŶiĐ iŶduĐeƌs ǁeƌe ƌefeƌƌed as ͞CoŶtƌol͟ 
aŶd Đultuƌes gƌoǁŶ iŶ osteogeŶiĐ ŵediuŵ ;OMͿ ǁith deǆaŵethasoŶe as ͞OMϭ͟ aŶd 
osteogenic medium with dexamethasone and β-glicerol-phosphate ŵediuŵ as ͞OMϮ͟. 
 
 
Figure 8 ADSCS in primary culture (40x) 
 
Cell proliferation  
Total DNA content was assayed and results presented in Graphic 1. Control cell 
cultures of ADSCs derived from FUAL increased the proliferation from day 1 to day 11 
of culture, diminishing afterwards. Cell proliferation increased in both osteogenic 
medium (OM1 and OM2) during the days of culture. Nonetheless, comparatively, OM 
media induced a reduced proliferation at late culture time points (i.e., at day 8 and 11). 
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Graphic 1 Cell proliferation of ADSCs from FUAL during the fifteen days of culture. CM: control 
medium; OM1: osteogenic medium with dexamethasone; OM2: osteogenic medium with β-glicerol-
phosphate; * - significantly different from control (p < 0.05). 
 
 
Metabolic activity  
Metabolic activity was evaluated by the MTT assay (Graphic 2). The cells from all 
groups gradually increased the metabolic activity during the 11 days of culture, 
diminishing afterwards. Significant differences were only verified at day 1, with 
osteogenic medium reducing the metabolic activity of the cultures. 
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Graphic 2 Metabolic activity of FUAL subjected to three different conditions. CM: control medium; 
OM1: osteogenic medium with dexamethasone; OM2: osteogenic medium with β-glicerol-phosphate. 
phosphate . * - significantly different from control (p < 0.05). 
 
Alkaline phosphatase activity  
The Graphic 3 shows the values of the normalized alkaline phosphatase activity that 
was performed on days on days 1, 4, 8, 11 and 15 of culture. The values of ALP activity 
of the three groups, was found to increase until day 11, and then, decreased with the 
culture time. Osteogenic medium, both OM1 and OM2, were found to increase ALP 
activity at day 11 of the culture, as comparing to control.  
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Graphic 3 Alkaline phosphatase activity (normalized by the amount of total protein) quantification 
during the fourteen days of culture. CM: control medium; OM1: osteogenic medium with 
dexamethasone; OM2: osteogenic medium with β-glicerol-phosphate.  * - significantly different from 
control (p < 0.05). 
 
 
Staining of alkaline phosphatase  
Optical microscopy images from alkaline phosphatase activity, evaluated by 
histochemical staining, are presented in Figure 9. On control, a dense monolayer 
organization can be observed from cells grown up to day 11. With the addition of 
osteogenic inducers, a change in the culture morphology occurs, with the formation of 
nodular structures in which grown cells converge to. Comparatively, OM2 seems to 
induce a greater nodular organization (with darker and better organized nodules) than 
OM1, as observed by the histological staining at day 11.  
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Figure 9 Microcopy images from alkaline phosphatase histochemical on day 11 and 15. CM: control 
medium; OM1: osteogenic medium with dexamethasone; OM2: osteogenic medium with 
dexamethasone and β-glicerol-phosphate. Magnification of 40x for images from day 11 and 
magnification of 100x for images from day 15. 
 
 
Staining of collagen 
Optical microscopy images from collagen staining as assessed histochemical are 
presented in Figure 10. In control, an homogenous cell layer is observed at day 11, 
staining positive for total collagen. Osteogenic medium induced a nodular organization 
of the culture, with an increased stain at the nodular structures. While a distinct 
morphologic organization is verified in osteogenic medium cultures, in comparison to 
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control, no significant differences are readly identified between the two osteogenic 
medium conditions. 
 
Figure 10 Microcopy images from collagen (Sirus Red) histochemical on day 11 and 15. CM - control 
medium; OM1- osteogenic medium with dexamethasone; OM2 - osteogenic medium with β-glicerol-
phosphate. Magnification of 40x for images from day 11 and magnification of 100x. 
 
Gene expression analysis 
ADSCs cultures derived from FUAL were analyzed by RT-PCR at day 8. The genes 
analyzed were the housekeeping GAPDH, the osteogenic transcription factor Runx-2, 
the adipogenic transcription factor PPAR-γ, the ŵusĐulaƌ tƌaŶsĐƌiptioŶ faĐtoƌ MǇoD 
and the chondrogenic transcription factor Sox9. The results shown in Graphic 4 were 
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normalized by the value obtained for GAPDH on each experimental condition. 
Significant differences were only attained regarding the increased expression of PPAR-
γ ǁith the OMϮ.   
 
 
Graphic 4 RT-PCR gene expression of Runx-2, PPAR-γ, MǇoD and Soǆ-9 in ADSCs derived from FUAL in 
the absence (CM) and presence of ostegenic inductors (OM2) on day 8 of culture. * - significantly 
different from control (p < 0.05). 
 
ASCS FROM FDAL 
The cells harvested and processed from each anatomical local were cultured in control 
medium (see Figure 11) as previously described. Following, the first subcultures were 
evaluated for cell morphology, proliferation, viability and osteoblastic differentiation, 
following specific induction, during 15 days.  
Cultuƌes estaďlished iŶ ĐoŶtƌol ŵediuŵ ǁeƌe ƌefeƌƌed as ͞CM͟ aŶd Đultuƌes gƌoǁŶ 
ǁith deǆaŵethasoŶe aŶd β-glǇĐeƌophosphate as ͞OMϮ͟. 
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Figure 11 ADSCs from different anatomical sites in primary culture at day 15 (40x). 
 
Cell proliferation  
Graphic 5 shows the results of cell proliferation that was assessed by DNA 
quantification during the time of culture. It is possible verify that ADSCs from distinct 
anatomical locations reveal different proliferation rates. For instance, ADSCs from 
abdominal inguinal report an increased initial proliferation attain the highest peak at 
day 8 of culture. Cultures grown from subcutaneous inguinal and flank, achieved the 
highest peak at day 11, while cultures from the neck and omentum increased 
proliferation continuously, until day 15. Despite the different proliferative behaviours, 
the presence of the OM within the culture microenvironment was broadly found to 
reduce cell proliferation, particularly from day 8 onwards. The cell proliferation of 
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cultures established from the neck was the one to be the least affected by OM, as no 
significant differences were found between experimental conditions. 
 
 
Graphic 5 Cell proliferation of ADSCs from FDAL in the absence (CM) and in presence of osteogenic 
medium (OM2).  * - significantly different from control for each individual anatomical local (p < 0.05). 
 
Metabolic activity  
Metabolic activity was evaluated through MTT assay (Graphic 6). In control conditions, 
the metabolic activity was broadly found to increase until day 11, diminishing 
afterwards. Cultures established from abdominal inguinal fat achieved the highest MTT 
reduction value at day 8. Generally, MTT reduction values were diminished when 
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cultures were grown in the presence of OM, with the exception of those established 
from neck, in which the metabolic activity of the cultures was induced. 
In all anatomical locals, except in abdominal inguinal control, flank and neck with 
osteogenic medium, the metabolic activity increase gradually from day 1 to day 11 and 
then decrease.  In abdominal inguinal control, the higher value of MTT was observed 
on day 8, occurring a decrease to day 11 and then, to day 15, the value increased. In 
flank and neck the metabolic activity of ADSCs culture increased during the all time of 
culture. 
 
Graphic 6 Metabolic activity of ADSCs from FDAL in absence (CM) and presence of osteogenic medium 
(OM2). * - significantly different from control for each individual anatomical local (p < 0.05). 
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Cell morphology 
CLSM was the method used for the assessment of cell morphology and the acquired 
images are showed in Figure 12. There were no significant differences between 
anatomical locals. Broadly, cells grown presented a characteristic fibroblastic 
morphology with several cytoplastic processes and an intense actin staining at the cell 
border. No significant differences were found on themorphology between ADSCs from 
different locations, despite the variability of the cell number. 
 
Figure 12 CLSM imaging of ADSCs derived from FDAL on day 3 in the absence (CM) and presence of 
osteogenic inductors (OM2). Cytoskeleton was stained green and nucleus counterstained in red. 
 
Alkaline phosphatase activity  
The values of alkaline phosphatase (ALP) activity presented in Graphic 7, were 
normalized to the amount of DNA. Broadly, ALP activity increased throughout the 
culture period, with the exception of cultures grown from abdominal inguinal fat, in 
which the peack of activity was attained at day 8. Broadly, in cultures established from 
all the anatomic locations, the presence of OM2 was found to significantly increase the 
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ALP activity. Comparatively, higher ALP activity was attained for cultures grown from 
flank and omentum. 
 
 
 
Graphic 7 ALP activity of ADSCs from FDAL in absence (CM) and presence of osteogenic medium 
(OM2).  * - significantly different from control for each individual anatomical local (p < 0.05). 
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Staining of alkaline phosphatase  
Optical microscopy images from alkaline phosphatase activity, evaluated by 
histochemical staining, are presented in Figure 13. Broadly, the staining intensity is 
verified to increase throughout the culture time for control cultures, established from 
the different anatomical locations, with the exception of cultures grown from 
abdominal inguinal region, that reveal a higher cell density and staining intensity at day 
8. Cultures grown in osteogenic-inducing conditions (OM medium) present an 
increased staining intensity and a modification in the morphological organization of 
the culture. From day 8 onwards, cells converge to the organization of nodular 
structures that stain intensively. With the increase in culture time, the nodular 
structures seem to become densely organized with an increased staining intensity. This 
beahviour is not broadly verified on cultures established on control conditions and 
remnants of nodular organization can only be initially disclosed on subcutaneous 
inguinal, flank and neck ADSCs-derived cultures, at day 15.  
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Figure 13 Alp staining of different ADSC's from FDAL, in the absence and in the presence os osteogenic 
inducers. CM – Control Medium; OM2 - ostegenic medium with dexamethasone and β-
glycerophosphate. Magnification 100x. 
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Staining of collagen 
Optical microscopy images from collagen staining as assessed histochemically are 
presented in Figure 14. The collagen staining seems to increase, in control cultures, 
throughout the culture period. Remarkably, ADSCs grown from omentum seem to 
display the highest collagen staining. 
 With the induction with OM, cultures were found to organize in nodular structures, in 
a similar fashion to that previously described following the assessment of the staining 
of ALP activity. The staining intensity was also found to increase within the nodular 
structures throughout the culture period, being the highest at day 15. The nodular 
organization of control cultures, as verified with the ALP staining, is less evident with 
this histochemical staining.   
It is possible to observe differences between the cells from anatomical sites in study 
and between the days of culture. The ADSCs from all locals were initially dispersed, but 
over days they aggregated giving rise to nodular structures on day the eleventh and in 
osteogenic medium (OM2). The color intensity increased during the culture.  
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Figure 14 Colagen staining (Sirus Red) of different ADSC's from FDAL, in the absence and in the 
presence os osteogenic inducers. CM – Control Medium; OM2 - ostegenic medium with 
dexamethasone and β-glycerophosphate. Magnification 40x. 
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Staining of SA-βgal 
Senescent cells in FDAL cultures were detected by staining the cells on days 1 and 4. 
However, after observation by optical microscopy, it was possible to verify that blue-
stained cells (quiescent cells) were very reduced, and to low to be quantified. In the 
vast majority of observed microscopic fields no stained cells were identified witch 
precluded the calculation of the percentage of cells eǆpƌessiŶg β-galactosidade. In 
Figure 15, a rare example of senescent cell, found in ADSCs control culture, from 
inguinal subcutaneous local, on day 4 of culture, is presented. Stained cells were only 
identified in subcutaneous inguinal, abdominal inguinal and neck locations, at day 4, 
but in a very reduced proportion. 
 
Figure 15 Reprentative sstaining of senescence-associated beta-galactosidade activity (arrow)  from 
ADSCs control culture from inguinal subcutaneous local. Magnification 200x. 
 
Gene expression analysis 
ADSCs cultures derived from FDAL were analyzed by RT-PCR at day 8. The genes 
analyzed were the housekeeping GAPDH, the osteogenic transcription factor Runx-2, 
the adipogenic transcription factor PPAR-γ, the ŵusĐulaƌ tƌaŶsĐƌiptioŶ faĐtoƌ MǇoD 
and the chondrogenic transcription factor Sox9. The results shown in Graphic 8 were 
normalized by the value obtained for GAPDH on each experimental condition. It is 
possible verify that in cultures established from all anatomical locations, the 
osteogenic medium, was found to induce the expression of PPAR-γ. BƌoadlǇ, MǇoD 
expression was also enhanced in subcutaneous inguinal, abdominal inguinal and flank, 
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while in ADSCs from omentum, the OM was found to induce the expression of RUNX2 
and SOX9.  
 
Graphic 8 RT-PCR gene expression of Runx-2, PPAR-γ, MǇoD and Sox-9 in ADSCs derived from FDAL in 
the absence (CM) and presence of ostegenic inductors (OM2) on day 8 of culture. 
* - significantly different from control (p < 0.05); 
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Characterization of the three-dimension ADSC cultures 
(spheroids) 
The technique used to form the spheroids proved to be effective and after 24 hours of 
culture, the cells were found to aggregate and showed a spheroidal aspect. The 
spheroids from two experimental groups were cultured in control medium (OM) and 
osteogenic medium (CM1). 
ASCS FROM FUAL  
Spheroids from ADSCS from FUAL were maintained during 17 days and the culture was 
ended at this time point since the vast majority of spheroids grown from C=5x10
4 
cells/cm
2 
spontaneously disaggregated. Overall, the spheroid formation efficiency after 
24 hours was 75% in the C=20x10
4
 cells/cm
2 
and 100% in the C=5x10
4 
cells/cm
2 
(see 
Table 2). 
 
Figure 16 Photographs (phase-contrast) on day 1; A- cellular concentration of 20x104 cells/cm
2
 ; B - 
cellular concentration of 5x104 cells/cm
2
. Scale bar of 325 µm. 
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Table 2 The table show the number efficiency of spheroid formation and area after 24 hours. The 
spheroid formation efficiency was as percentages of the number of formed aggregates in relation to 
the number of seeded aggregates (n). * - significantly different from C=20x10
4
cell/ml (p < 0.05). 
 
 
The Graphic 9 shows the cross-sectional area of spheroids during the 17 days of 
culture in the two concentrations. It is possible to verify that, comparatively, the 
spheroids were smaller when the initial cellular concentration was 5x10
4
 cel/cm
2
 . The 
spheroids cultured in osteogenic medium were always smaller than those cultured in 
control medium, for both concentrations. Further, either in control or osteogenic 
conditions, spheroids were found to decrease in size throughout the assayed 
experimental period.   
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Graphic 9 Cross-sectional area of ADSCs spheroids seeded of two different concentrations - C= 5x10
4
 
cel/cm
2
 (A) and C=20x10
4
 cel/cm
2 
(B) – in the absence (CM) and presence of osteogenic inductors 
(OM2) during 17 days of culture. * - significantly different from day 4 (p < 0.05). 
 
 
During the days of culture, some spheroids were lost, due to, mainly, the change of 
culture medium. The Table 3 showed the number of spheroids (N.S.) and the 
maintenance rate (M.R.) during the 17 days of culture. The spheroids formed with 
20x10
4
 cells/cm
2
 kept the highest value of M.R. during the whole culture 
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Table 3 The table show the number of spheroids (N.S.) and the maintenance rate (M.R.) of spheroids 
in relation to the number of formed aggregates at 24 hours during the 17 days of culture. 
 
ADSCS FROM FDAL 
Spheroids generated from ADSCS from FUAL were cultured during 6 days. After 24 
hours, the cells derived from all locals formed the spheroids, but the number of 
spheroid formed varied greatly among the assessed anatomic locations (see Table 4). 
“pheƌoids foƌŵed ďǇ AD“C͛s deƌiǀed fƌoŵ aďdoŵiŶal iŶguiŶal aƌea shoǁed a 
formation efficiency higher than 96%, but in the omentum the formation efficiency 
was only 59.4%. 
After 24 hours, the flank spheroids showed the highest surface area, whereas the 
subcutaneous inguinal the lowest (see Table 4). 
The Figure 17  show the photographs (phase-contrast) of spheroids at 24 hours after 
Đultuƌe aŶd oŶ daǇ ϲ. It͛s possiďle ǀeƌifǇ the diffeƌeŶt ŵoƌphologǇ ďetǁeeŶ the  
anatomical locals and during the days of culture.  
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Table 4 The table show the efficiency of spheroid formation and the mean area after 24 hours in the 
five anatomical locals. The spheroid formation efficiency was as percentages of the number of formed 
aggregates in relation to the number of seeded. 
 
Over the days, the number of spheroids in culture decreased, manly, due to the 
medium changes. The maintenance rate (M.R.), ration between spheroids at day 6 in 
relation to the number of formed aggregates after 24h, was showed in Table 5. The 
flank spheroids had the highest M.R. and the subcutaneous inguinal spheroids the 
lowest M.R.. 
 
Table 5 The table show the number of spheroids at day 6 and the maintenance rate (M.R.) of 
spheroids at day 6 in relation to the number of formed aggregates at 24 hours in different anatomical 
locals. 
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Figure 17 Photographs (phase-contrast) of spheroids at 24 hours after culture and on day 6. Scale bar 
of 325 µm. 
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On day 6, spheroids cultured in the presence of osteogenic medium (OM2) presented a 
reduced cross-sectional area, as comparing to control (Graphic 10). 
 
Graphic 10 Cross sectional area of ADSCs spheroids from different anatomical locals at day 6 in the 
absence (CM) and presence of osteogenic inductors (OM2).  * - significantly different from control (p < 
0.05). 
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The adipose-derived stromal cells (ADSCs) are quite promising in regenerative 
medicine, namely in orthopedic tissue engineering. These cells can be obtained in large 
quantity and through a minimally invasive method. Moreover, they have the ability to 
differentiate themselves into multiple lineages allowing an application in various fields 
of regenerative medicine [23], [122]. 
From among all the factors which may influence the proliferation and the 
differentiation capacity of adipose-derived stromal cells isolated from stromal vascular 
fraction (SVF), the harvest site of adipose tissue has gained great importance [65], [67], 
[69], [70], [123], [124].  
The main goal of this work was established a ADSCs culture from different rat 
anatomical sites to verify if there were differences in yield, proliferation and 
osteogenic capability of expanded and differentiated of that cells.  
Thus, in a first part of this study, we established a culture of adipose-derived stromal 
cell (ADSCs) from undifferentiated anatomical locals (FUAL). The rat adipose tissue was 
harvested randomly from the places where more fat was available. After isolation of 
ADSCs from SVF through collagenase digestion, cells were seeded given rise to a 
primary culture that was established for seven days – around 70-80% confluence. 
Afterwards, a first-subculture was established and the cells were cultured in three 
different conditions – control medium (CM), osteogenic medium with dexamethasone 
(OM1) and osteogenic medium with dexamethosone and β-glicerol-phosphate 
medium (OM2) – during 15 days. The dexamethasone is synthetic glucocorticoid and is 
known as an osteogenic inductor in MSCs [36], [125]–[127] aŶd β-glicerol-phosphate, 
which is also an osteogenic inducer,  capable of induce calcification and mineralization 
of the extracellular matrix [54], [127], [128]. The monolayer culture from FUAL was 
then characterized assessing the cell morphology, proliferation, metabolic activity, and 
osteogenic capability, by histochemical staining and gene expression analysis. Further, 
in order to disclose the differentiation capability of the grown cells, the expression of 
significant transcription factors of the osteogenic, adipogenic, myogenic and 
chrondogenic lineages were also evaluated.   
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Cell proliferation was evaluated by DNA quantification and the results showed that, in 
control, cells proliferated actively until day 11, diminishing afterwards. With OM 
induction, cells proliferated actively throughout the assayed culture period but a 
reduced cell proliferation was verified, from day 8 onward, as comparing to control. 
The metabolic activity of the cultures followed a similar trend: increasing until day 11 
on control, and throughout the assayed culture period in OM conditions. 
Comparatively, OM induction was not found to significantly influence the metabolic 
activity of the cultures. Accordingly, osteogenic induction with dexamethasone and 
beta-glicerophosphate has been previously found to alter the proliferation of 
precursor populations. While known to induce the osteogenic differentiation, cell 
proliferation is broadly hampered by osteogenic inducers given the enhanced culture 
commitment to differentiation activities [22], [127], [129]. 
The alkaline phosphatase activity is an indicator of the osteogenic differentiation in 
vivo and in vitro. Within established differentiating osteogenic cultures ALP is normally 
increased at early culture time points and peaks just before the initiation of the 
mineralization process, diminishing afterwards [111], [114], [130]. Histochemical 
staining for ALP can be correlated the biochemical determination being possible to 
verify the presence of nodular structures, on days 11 and 15 on OM-induced cultures 
(more evident on OM2), which is characteristic of the osteogenic differentiation 
process [130], [131]. Histochemical staining correlated well with biomechanical 
determination of ALP activity, in which is verified the maximum activity of cultures 
grown for 11 days on OM2 conditions. Regarding collagen expression, by observing the 
established cultures, an increase staining is verified with the increase in culture time. 
In OM, it is possible observe that cells tend to form clusters; which is associated with 
an increased staining of collagen. This pattern of expression is common during the 
osteoblastic differentiation, as previously verified by other reports [53], [127], [131], 
[132]. 
The RT-PCR analysis was performed only in two groups – control (CM) and osteogenic 
medium 2 (OM2), given the increased osteogenic induction verified with this 
condition. Broadly, the expression of transcription factors of distinct differentiation 
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lineages were assessed: Runx-2 (osteogenic), Sox-9 (condrogenic), PPAR- γ ;adipogeŶiĐͿ 
and MyoD (myogenic).  
Runx-2 is the central control gene for osteoblast phenotype. This gene provides 
instructions for making a protein that is involved in bone development and 
maintenance. It is essential for osteoblastic differentiation and acts as a scaffold for 
nucleic acid and regulatory factors involved in skeletal gene expression [133]. Sox-9 is a 
master transcription factor for chondrogenic differentiation and it is expressed in all 
chondro-progenitor cells and in differentiated chondrocytes. Sox-9 is essential during 
the embryonic chondrogenesis but also expressed in adult tissues, being crucial for 
chondrogenic differentiation of mesenchymal stromal cells [134]. PPAR-γ is a ŵeŵďeƌ 
of the nuclear hormone receptor family and it is predominantly expressed in adipose 
tissue and is required for adipogenesis in vivo and in vitro [135], [136]. MyoD is a 
protein that belong to the family of myogenic regulatory factors and are expressed 
earlier during muscle development and are involved in the determination of the 
myogenic lineage [137]. Within the induction with OM2, no significant differences 
were found regarding the expression of the assayed transcription factors, except for 
PPAR-γ, ǁhiĐh eǆpƌession was found to increase. This was unexpected, given the 
previously verified changes in the culture morphology and increased in ALP and 
collagen expression, during OM-induction. Accordingly, it might be expected to verify 
an increase in RUNX2 expression. Despite the absence of RUNX-2 up-regulation, one 
cannot preclude the effective and increased osteogenic commitment of grown ADSCs 
from FUAL, with OM induction, particularly given the increased markers of osteogenic 
commitment – increased ALP activity and collagen expression, and characteristic 
organization of the culture in nodular structures. 
Despite the attained results, some factors could converge to assist on the verified 
results. Gene expression analysis was conducted at day 8, in which the nodular 
arrangement of the culture was already verified following OM treatment, supporting 
the effective osteogenic commitment. As so, RUNX2 activity could have been 
upregulated earlier than day 8, contribute to an effective osteogenic commitment, and 
being following downregulate to basal levels [133]. In order to verify this hypothesis, 
gene expression analysis could be further conducted at earlier time points to disclose 
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the effective activation of RUNX2, and also, at later time points, in order to address the 
expression of later markers of osteogenic development, such as osteocalcin and bone 
sialoprotein [133]. 
One may not also neglect that dexamethasone, used within the OM composition,  is 
also broadly employed in adipogenic differentiation of MSCs [127] and even within the 
osteogenic differentiation, spontaneous adipogenic differentiation may also occur, as 
previously reported [126], [136]. This might be related to the wide variability of cell 
populations present in the SVF. In fact, these were shown to include potential ADSCs, 
endothelial (progenitor) cells, pericytes, blood-derived cells, fibroblasts, vascular 
smooth muscle cells, and preadipocyte [138]. 
The differentiation potential of ADSCs is also a matter of debate. The in vitro 
differentiation of ADSCs into multiple cell types of mesodermal origin has been shown 
in a wide variety of studies and experimental conditions, with ADSCs being cultured by 
serial passaging, without losing their multipotent properties. Different studies 
described ADSCs plasticity towards chondrocytes, osteoblasts, adipocytes, and 
myocytes, as well as to differentiate into lineages of nonmesodermal origin [139], 
[140]. However, at the single cell level, ADSCs demonstrated that not every cell 
possesses the characteristic trilineage mesenchymal differentiation potential for 
adipogenesis, osteogenesis, chondrogenesis, using lineage-specific differentiation 
media. Cell clones from human ADSCs were found to differentiate into at least one of 
the lineages in 81% of the situations, while only 52% of the clones differentiated into 
two or more of the lineages [141], sustaining the high variability of the differentiation 
potential of ADSCs.  
Furthermore, and apart from the established compositional variability, one may not 
also forget that phenotype expression is related to the plastic adherent capabilities of 
the cells and that cultured population dramatically changes the phenotype very early 
during cell culture [3]. 
Some authors sustain that the heterogeneity of cultured ADSCs can presumably be 
reduced by a washing procedure at early culture time points, or by applying flow 
cytometric cell sorting methodologies, either of positive or negative discrimination, in 
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order to include or exclude specific populations [142]. Nonetheless, the usage of such 
techniques for the reduction of heterogeneity is arguably beneficial since it leads to a 
very small cell yield, which may significant hamper the usability of the fat tissue as a 
source of MSCs-like populations for regenerative approaches. 
Following, and set on data of ADSC cultures established from FUAL, ADSC cultures 
established fat, harvested from different anatomical sites was conducted. Current 
evidence shows a distinct biological behavior, with numerous biological and genetic 
differences between the adipose tissue of distinct anatomical locations [143]. For 
instance, in humans, the upper body/visceral fat tissue is broadly associated with 
metabolic complications, in antagonism to the fat accumulation in the lower body 
[144]. In fact, visceral fat has been associated with an increased inflammatory milieu, 
through the production of pro-inflammatory cytokines, at the expense of adiponectin 
production – which endeavors an insulin resistance profile and favors the development 
of atherosclerosis [145]. Correlating with the distinct biological behavior of the fat 
tissue in distinct anatomic locations, the secretome analysis of visceral, subcutaneous, 
and gonadal fat revealed differentially secreted proteins among the three fat depots, 
showing that that the type of proteins and their role in different biological processes 
diverged significantly, thus emphasizing and supporting the differential role of adipose 
tissue in accordance to its anatomical localization [146]. 
In this work, it was verified a distinct biological behavior of grown cultures of ADSCs 
isolated from distinct anatomic locations. In which regards the proliferative capacity, 
abdominal inguinal revealed the highest potential (with the highest value being 
attained at day 8 of culture), with the cells from omentum and neck showing the 
lowest proliferative potential (proliferation increased throughout the 15 days of the 
culture), and subcutaneous inguinal and neck, with intermediate proliferative capacity. 
Cultured ADSCs were previously shown to have an extensive proliferative ability, 
broadly found to be superior to that verified in other MSCs from distinct locations, 
such as the bone marrow [147]. Furthermore, established cell cultures, at passage 1, 
also revealed a very high viability and broadly low senescence (as assessed 
histochemically in this work), which is in accordance with previously reported data 
[22].   
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In regards to the osteogenic capability, broadly assessed by the quantitative 
determination of ALP activity, this was found to be the highest in ADSC cultures from 
flank, and then decrease within those from omentum, neck, subcutaneous inguinal 
and abdominal inguinal, respectively. OM induction broadly decreased cell 
proliferation but increased ALP activity, thus supporting the effective osteogenic 
differentiation of the grown ADSCs [21], [22], [127]. Attained biochemical data 
correlated well with histochemical analysis. This further revealed the nodular 
organization of the cultures grown within OM-induction, which is characteristic of the 
osteogenic phenotype [127], [130], [131]. Cultures grown in the presence of OM were 
also found to increase the collagen expression, which is in accordance with their 
effective osteogenic commitment [118], [127]. 
In terms of the assessment of the expression of transcription factors, in a similar 
fashion to the observed data in FUAL, OM-induction broadly increased PPAR-γ 
expression in cultures from all anatomical locations. While MyoD expression was also 
increased in subcutaneous inguinal, abdominal inguinal and flank, within cultures 
derived from omentum, Runx2 and Sox9 were significantly increased. While gene 
expression analysis should further be validated by specific lineage-induction 
differentiation and confirmation of cell differentiation by specific protein analysis, 
attained data may suffice to validate a distinct biological behavior of ADSCs isolated 
from distinct anatomical locations. In which regards to osteo/chondral-related 
applications, cells isolated from omentum, reporting high ALP activity and enhanced 
RUNX2 and SOX9 activation following OM-induction, show the most promising 
potential for application in regenerative medicine applications targeting bone and 
cartilage. 
While no other study particularly addresses the biological characterization of ADSCs 
from so many distinct anatomical regions, there are some data on literature that 
converge to sustain a differenced behavior of cell populations isolated from different 
fat depots. Of relevance within osteo/chondral-related applications, the study of 
Jurgens et al. [65] addresses the evaluation of human subcutaneous adipose tissue 
from abdomen and hip/thigh region, in terms of cell yield and the functional 
characteristics of harvested ADSCs, following chondrogenic and osteogenic 
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differentiation. The results obtained showed that the lineage-induced ADSCs from 
hip/thigh region tended to show higher levels of alkaline phosphatase activity than 
those from the abdomen region, but in chondrogenic differentiation, no difference 
were detected between the cells grown from the two anatomical regions. However, 
the yield of ADSCs, but not the total amount of nucleated cells per volume, were found 
to be higher within the abdomen-derived fat, rather than within the fat of the 
hip/thigh region [65]. 
Emre et al. addressed the osteogenic behavior of lineage-induced human ADSCs from 
superficial and deep adipose layers of abdominoplasty specimens [148]. The authors 
found that the osteogenic differentiation began as early as 1 week and while there was 
no significant difference in the degree of osteogenic differentiation between the 
ADSCs from both depots in female donors, in assessed male-derived ADSCs, those from 
the superficial depot differentiated faster and more efficiently than those from the 
deep depot. Furthermore, male cells from both depots differentiated more effectively 
than female ADSCs from both depots, which support the existence of differences in the 
biological behavior of cells isolated from distinct anatomical locations, but also gender-
specific differences.  
Following to the characterization of the established ADSC cultures in two dimensions, 
three dimensional cultures were also developed following induction of cell 
aggregation, and were characterized in order to disclose the cell behavior in 3D 
conditions, in the absence of any given substrate.  
The use of a non-adhesive surface to prevent the cellular adhesion is widely applied to 
mimic the in vivo three-dimensional environment [83]. The liquid overlay technique 
(LOT) is a technique based on this principle and proved to be efficient for the 
formation of ADSC spheroids. In the present work, 96-wells plates were coated with 
1% of agarose solution and isolated cells were seeded at two different concentrations, 
5x10
4
 cel/cm
2  
and  20x10
4
 cel/cm
2
.  
After 24 hours of incubation under standard cell culture conditions, cell aggregates 
were visible in the assayed cell concentrations. However, the spheroid formation 
efficiency was not the same for both concentration, being 100% on C=5x10
4
 cel/cm
2
 
Elisabete Gonçalves 
80 
 
and 75% on C=20x10
4
 cel/cm
2
.  Further, the mean area of the attained spheroids was 
higher with the cellular concentration of C=20x10
4
 cel/ cm
2
, which is in accordance 
with the higher cell density used. Throughout the culture period, larger spheroids 
(those from C=20x10
4
 cel/ cm
2
) were more easily identified and the handling during 
medium change was easier, which is proven by higher maintenance rate.  Spheroids 
grown in the presence of OM revealed a reduced size, as comparing to those grown in 
control conditions. Osteogenic induction is expected to induce changes in the 
functional activity of the cells, and thus affect cell-to-cell interactions, as well as the 
extracellular matrix formation and composition, which may further contribute to 
sustain the verified reduced spheroid diameter [94]. Furthermore, along culture time, 
and in all experimental conditions, the area of spheroids decrease progressively. This 
can be explained by the inefficient mass transport and the accumulation of metabolic 
waste inside the spheroids, which leads to the formation of necrotic core [86]. 
Moreover, cell aggregation is expected to increase with culture time due to hemophilic 
cadherin-cadherin interactions [86].  
In the last days of the culture, the vast majority of the spheroids of C=5x10
4
 cel/cm
2 
spontaneously disaggregated, while those from C=20x10
4
 cel/cm
2 
remained viable. 
Accordingly, this concentration was selected for the following experimental setting 
that aimed the characterization of spheroids from ADSCs derived from FDAL.  
The ADSCs from FDAL were cultivated at density of 20x10
4
 cells/cm
2
 and for each 
anatomical local 32 wells were prepared (coated with 1% of agarose solution).  
Three-dimensional aggregates were formed after 24 hours of seeding. The number of 
formed aggregates and, consequently, the spheroid formation efficiency differed from 
local to local. The cells derived from abdominal inguinal area formed more aggregates, 
31 in total, with a spheroid formation efficiency of 96.86% and the cells from omentum 
formed only 19 spheroids (spheroid formation efficiency of 59.38%). The low value for 
spheroids formed with ADSCs from omentum, may be related to the fact of ADSCs 
from this anatomical local showed the formation of multiple small spheroid per well, 
broadly two or three small spheroids were identified. These multi-spheƌoids ǁeƌeŶ͛t 
formed in other anatomical locals in study. Some of these multi-spheroids converged 
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and aggregated over the culture period. After 24 hours, the ADSCs from flank formed 
the largest spheroids with a mean area of 320.5 µm
2
 and the subcutaneous inguinal 
allowed the formation of spheroids with the smallest mean area, of 117.6 µm
2
.  
Throughout the culture period, spheroids became more compact and reduced in size – 
either in diameter and area. These date are consistent with the results of Metzger el al. 
[83] and Hildebrandt et al. [94] who observed a decrease in the spheroids diameter 
during the time of culture, an issue probably related to the inefficient mass transport 
and metabolic waste accumulation inside the spheroids which gives arise a necrotic 
core inside and a small proliferation zone in the periphery [86]. 
As previously reported for the spheroids organized with FUAL, osteogenic medium 
(OM) induction significantly reduced the size of the spheroids, in all anatomical 
locations. This may be related to the osteogenic commitment of the growing cells, 
which reveal a hampered proliferation at the expense of the functional activity being 
committed to the osteogenic differentiation. In order to further validate these 
observations, biochemical assays and gene expression analysis should be conducted.  
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Adipose-Derived Stromal Cells (ADSCs) have a self-renewing capability, as well as the 
ability to differentiate themselves into multiple lineages allowing the application in 
regenerative applications. Of relevance, their capacity to be inducted into the 
osteogenic lineage has found great interest in orthopedic tissue engineering 
applications.  
In this work, a two-dimensional and a three-dimensional culture system of osteogenic-
induced rat ADSCs, was established. Initially, fat from undifferentiated anatomical 
locals (FUAL) was isolated and established first subcultures were characterized. 
Following, fat from differentiated anatomical locals (FDAL), i.e., subcutaneous inguinal, 
abdominal inguinal, flank, neck and omentum, were adequately characterized. 
Cell cultures established from FUAL showed a distinct behavior from control, when 
subjected to osteogenic medium induction. The cell proliferation was hampered by 
osteogenic inducers while, the osteogenic differentiation was enhanced. This was 
verified by the alkaline phosphatase activity and by histochemical methods, verifying 
the presence of nodular structures within the induced cultures. 
Cultures established from FDAL showed a distinct biological behavior. In regards to the 
proliferative capacity, abdominal inguinal revealed the highest potential, while the 
osteogenic capability was highest in cultures established from flank, following specific 
osteogenic induction.  
Spheroids from FUAL and FDAL were efficiently formed after 24 hours of incubation. 
Over the days, spheroids decreased in terms of area and compared to the control 
medium, spheroids in OM were significantly reduced the size. These were found to 
maintain their viability throughout the culture period.  
Broadly, and given the verified functional differences of ADSCs grown from distinct 
anatomical locations, it might be adequately to address the fat tissue anatomical 
location in order to adequately select the populations most relevant for the specific 
targeted regenerative application, as significant differences in terms of cell 
proliferation and osteogenic differentiation capability were verified in the assayed 
experimental model. 
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